BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19261399)

  • 1. Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants.
    Antia U; Lee HS; Kydd RR; Tingle MD; Russell BR
    Forensic Sci Int; 2009 Apr; 186(1-3):63-7. PubMed ID: 19261399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans.
    Antia U; Tingle MD; Russell BR
    J Forensic Sci; 2010 Sep; 55(5):1311-8. PubMed ID: 20533987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo interactions between BZP and TFMPP (party pill drugs).
    Antia U; Tingle MD; Russell BR
    N Z Med J; 2009 Sep; 122(1303):29-38. PubMed ID: 19851418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ; Slaughter RJ; Vale JA; Beasley DM; Gee P
    Clin Toxicol (Phila); 2011 Mar; 49(3):131-41. PubMed ID: 21495881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.
    Thompson I; Williams G; Caldwell B; Aldington S; Dickson S; Lucas N; McDowall J; Weatherall M; Robinson G; Beasley R
    J Psychopharmacol; 2010 Sep; 24(9):1299-308. PubMed ID: 19329546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2010 Jan; 21(1):86-90. PubMed ID: 19359158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partying on? Life after BZP-based party pills.
    Green JA
    N Z Med J; 2008 Oct; 121(1283):35-42. PubMed ID: 18841183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Party pill' drugs--BZP and TFMPP.
    Antia U; Tingle MD; Russell BR
    N Z Med J; 2009 Dec; 122(1307):55-68. PubMed ID: 20148045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
    Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Party pills and drug-drug interactions.
    Murphy M; Antia U; Chang HY; Han JY; Ibrahim U; Tingle M; Russell B
    N Z Med J; 2009 Apr; 122(1293):3564. PubMed ID: 19448787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.
    Gee P; Richardson S; Woltersdorf W; Moore G
    N Z Med J; 2005 Dec; 118(1227):U1784. PubMed ID: 16372033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic effects and their action mechanism of the major active components of party pill drugs.
    Min CR; Kim MJ; Park YJ; Kim HR; Lee SY; Chung KH; Oh SM
    Toxicol Lett; 2012 Nov; 214(3):339-47. PubMed ID: 23026265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand.
    Wilkins C; Sweetsur P; Girling M
    Drug Alcohol Rev; 2008 Nov; 27(6):633-9. PubMed ID: 19378447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzylpiperazine: a drug of abuse?
    Johnstone AC; Lea RA; Brennan KA; Schenk S; Kennedy MA; Fitzmaurice PS
    J Psychopharmacol; 2007 Nov; 21(8):888-94. PubMed ID: 17606471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of N-benzylpiperazine and 1-(3-trifluoromethylphenyl)piperazine in rat plasma by HPLC-fluorescence detection and its application to monitoring of these drugs.
    Wada M; Yamahara K; Ikeda R; Kikura-Hanajiri R; Kuroda N; Nakashima K
    Biomed Chromatogr; 2012 Jan; 26(1):21-5. PubMed ID: 21387353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
    Lecompte Y; Roussel O; Perrin M
    Ann Pharm Fr; 2008 Mar; 66(2):85-91. PubMed ID: 18570904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination.
    Lin JC; Jan RK; Kydd RR; Russell BR
    Drug Test Anal; 2011 Sep; 3(9):582-5. PubMed ID: 21538945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on 1-benzylpiperazine (BZP) party pills.
    Monteiro MS; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2013 Jun; 87(6):929-47. PubMed ID: 23685794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the subjective and physiological effects of BZP combined with TFMPP in human males.
    Lin JC; Jan RK; Lee H; Jensen MA; Kydd RR; Russell BR
    Psychopharmacology (Berl); 2011 Apr; 214(3):761-8. PubMed ID: 21060995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.